Clinical Observation of Microwave Ablation of Adenomyopathy Under the Guidance of Percutaneous Ultrasound
Objective:To observe the effect of percutaneous ultrasound-guided microwave ablation on adenomyopathy.Methods:37 cases of adenomyopathy were selected and the efficacy was evaluated by the improvement of symptoms and the change of focal perfusion area before and after treatment.Results:37 patients,12 months after surgery:26 patients before the operation of dysmenorrhea,22 cases of dysmenorrhea relief,improvement rate of 84.60%;The 29 patients with hypermenorrhagia before operation,26 cases recovered to normal,the improvement rate was 89.70%.Before operation,the average hemoglobin of 23 patients with anemia was(89.6±12.6)g/L,and 21 patients recovered to normal,the average hemoglobin was(118.2±12.3)g/L,the improvement rate was 91.30%(21/23).The lesion volume of 37 patients with adenomyosis was(152.76±68.58)cm3 before surgery and(10.03±8.36)cm3 12 months after surgery,the difference was significant(P<0.05).Among the 37 patients,19 patients had a significant therapeutic effect,17 patients were effective and 1 patient was ineffective.The total effective rate reached 97.30%.Conclusion:Percutaneous ultrasound-guided microwave ablation in the treatment of adenomyopathy can significantly improve dysmenorrhea,excessive menorrhea,anemia,etc.,reduce the size of the lesion,less trauma,and have a good effect.